Rotigotine polyoxazoline conjugate SER-214 provides robust and sustained antiparkinsonian benefit

Bioconjugation of Polymers: A Novel Platform for Targeted Drug Delivery

(2012) Ankur Vaidya et al.   CURRENT PHARMACEUTICAL DESIGN

Levodopa/carbidopa intestinal gel infusion long-term therapy in advanced Parkinson’s disease

(2012) D. Nyholm et al.   EUROPEAN JOURNAL OF NEUROLOGY

Polyoxazoline: Chemistry, Properties, and Applications in Drug Delivery

(2011) Tacey X. Viegas et al.   BIOCONJUGATE CHEMISTRY

Continuous drug delivery in early- and late-stage Parkinson’s disease as a strategy for avoiding dyskinesia induction and expression

(2011) P. Jenner et al.   JOURNAL OF NEURAL TRANSMISSION

Continuous dopaminergic stimulation and novel formulations of dopamine agonists

(2011) Fabrizio Stocchi   JOURNAL OF NEUROLOGY

Safety and Efficacy of Rotigotine in Individuals with Parkinson's Disease Aged 75 and Older

(2011) Alfonso Fasano et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease

(2011) Susan H. Fox et al.   MOVEMENT DISORDERS

Pulsatile or continuous dopaminomimetic strategies in Parkinson's disease

(2011) Daniela Calandrella et al.   PARKINSONISM & RELATED DISORDERS

Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE-PD study

(2010) Fabrizio Stocchi et al.   ANNALS OF NEUROLOGY

Tolerability and Safety of Ropinirole versus Other Dopamine Agonists and Levodopa in the Treatment of Parkinsonʼs Disease

(2010) Jaime Kulisevsky et al.   DRUG SAFETY

Poly(2-oxazoline)s: A Polymer Class with Numerous Potential Applications

(2009) Richard Hoogenboom   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease

(2009) David Devos et al.   MOVEMENT DISORDERS

Continuous dopaminergic stimulation achieved by duodenal levodopa infusion

(2009) Per Odin et al.   NEUROLOGICAL SCIENCES

Pros and cons of apomorphine and l-dopa continuous infusion in advanced Parkinson's disease

(2009) Angelo Antonini et al.   PARKINSONISM & RELATED DISORDERS

Therapeutic strategies to prevent motor complications in Parkinson’s disease

(2008) Karl Kieburtz   JOURNAL OF NEUROLOGY

Synthesis and characterization of poly(2-ethyl 2-oxazoline)-conjugates with proteins and drugs: Suitable alternatives to PEG-conjugates?

(2007) Anna Mero et al.   JOURNAL OF CONTROLLED RELEASE